Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AstraZeneca, Pozen Get FDA Approval for Vimovo | Contract Pharma

What are you searching for?

Sign in

AstraZeneca, Pozen Get FDA Approval for Vimovo

AstraZeneca and Pozen, Inc. received approval from the FDA for Vimovo (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AstraZeneca and Pozen, Inc. received approval from the FDA for Vimovo (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is a fixed-dose combination of enteric-coated naproxen, a pain-relieving non-steroidal anti-inflammatory drug (NSAID), and immediate-release esomeprazole, a proton pump inhibitor (PPI).

The approval was based on clinical data which showed that patients taking Vimovo experienced significantly fewer endoscopic gastric ulcers, compared to patients receiving enteric-coated naproxen.

“In a single pill, Vimovo provides a proven pain reliever with a built-in PPI for arthritis patients at-risk for NSAID-associated gastric ulcers,” said Howard Hutchinson, M.D., chief medical officer, AZ. “The approval also demonstrates the commitment of AstraZeneca and Pozen to provide a new pain relief option that addresses the unmet medical needs of these patients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters